2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with sesamin in 1 studies
| Studies (2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman) | Trials (2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman) | Recent Studies (post-2010) (2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman) | Studies (sesamin) | Trials (sesamin) | Recent Studies (post-2010) (sesamin) |
|---|---|---|---|---|---|
| 45 | 4 | 7 | 429 | 9 | 277 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, J; Graeve, L; Grebenstein, N; Schumacher, M | 1 |
1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and sesamin
| Article | Year |
|---|---|
α-Tocopherol transfer protein is not required for the discrimination against γ-tocopherol in vivo but protects it from side-chain degradation in vitro.
Topics: alpha-Tocopherol; Animals; Carrier Proteins; Chromans; Dioxoles; Female; gamma-Tocopherol; Hep G2 Cells; Humans; Lignans; Liver; Mice; Mice, Knockout; Mixed Function Oxygenases; Oxidation-Reduction; Propionates | 2014 |